Safety Evaluation of a New Preservative in a Lubricating Eye Drop
NCT01434277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2011-09-14
Summary
This study is to evaluate the safety of a new preservative in a lubricant eye drop used four times a day in healthy adults and subjects diagnosed with dry eye.
Conditions
- Dry Eye Syndromes
Interventions
- OTHER
-
Eye Drops with Experimental Preservative
Glycerin, Hypromellose, Polyethylene glycol 400 with experimental preservative PQ-42
Sponsors & Collaborators
-
Johnson & Johnson Consumer and Personal Products Worldwide
lead INDUSTRY
Principal Investigators
-
Sherryl Frisch · Johnson & Johnson Consumer and Personal Products Worldwide
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2011-04-30
- Completion
- 2011-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop
NCT00243711 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy of Investigational OTC Eye Drops
NCT03198000 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
NCT01459588 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.
NCT02553772 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
NCT05661851 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
NCT00932477 ·Status: COMPLETED ·Phase: NA
-
Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye
NCT06162442 ·Status: RECRUITING
-
Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer Thickness
NCT01066988 ·Status: COMPLETED ·Phase: NA
-
Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease
NCT06444516 ·Status: COMPLETED ·Phase: NA
-
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT00135824 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PMCF Study to Evaluate Performance and Safety of "Distilled Waters-based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05825586 ·Status: COMPLETED ·Phase: NA
-
A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
NCT05411367 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
NCT01476332 ·Status: COMPLETED ·Phase: PHASE1
-
Objective Evaluation of Ocular Surface Lubricants in Two Environments
NCT01375582 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
NCT03502447 ·Status: TERMINATED ·Phase: NA
-
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
NCT02280473 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
NCT05467293 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AG-80308 in Dry Eye Patients
NCT05372107 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of FID 114657 in Sjogren's Syndrome Subjects
NCT01079871 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of PG101 for Dry Eye Syndrome
NCT02078661 ·Status: COMPLETED ·Phase: PHASE1/PHASE2